In a recent public meeting, FDA and pharma industry officials met to discuss the standards and architecture required for companies to successfully comply with the Drug Supply ...
President Obama signed the 21st Century Cures Act this month, with aims for modernizing and improving the efficiency of drug and device approvals, as well as clinical trial design...
President Obama signed the 21st Century Cures Act this month, with aims for modernizing and improving the efficiency of drug and device approvals, as well as clinical trial design...